Literature DB >> 4730488

Inhibition of adrenergic cardiopathies by drugs. 3. Oxyfedrin.

F W Eichbaum, W J Yasaka, E P dos Campos, S Zyngier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4730488     DOI: 10.1007/BF01906172

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


× No keyword cloud information.
  10 in total

1.  [ON LATE CHANGES IN THE RAT MYOCARDIUM AFTER EXPERIMENTAL CORONARY INSUFFICIENCY].

Authors:  G KORB; V TOTOVIC
Journal:  Frankf Z Pathol       Date:  1963-11-18

2.  Cardioselective beta-receptor stimulant properties of oxyfedrine.

Authors:  W Osswald; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

3.  [Mechanism of action of oxyfedrin].

Authors:  S Habersang
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

4.  [Electron microscopic studies on the effect of alupent on the ultrastructure of the myocardium in rats].

Authors:  T U Hausamen; R Poche
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1965-06-01

5.  [The differential therapy of ischemic heart disease].

Authors:  K Donat
Journal:  Med Klin       Date:  1968-11-08

6.  Myocardial resistance. A study of its development against toxic doses of isoproterenol.

Authors:  J Dusek; G Rona; D S Kahn
Journal:  Arch Pathol       Date:  1970-01

7.  Inhibition of adrenergic cardiopathies by drugs. I. Dipyridamole.

Authors:  F W Eichbaum; S Zyngier; E P De Campos
Journal:  Arch Kreislaufforsch       Date:  1970 May-Jun

8.  [Effect of oxyfedrine on myocardial lesions in rats].

Authors:  P Plamenac; P Stern
Journal:  Wien Klin Wochenschr       Date:  1970-01-09       Impact factor: 1.704

9.  [Cardio-energetic heart therapy].

Authors:  J Beyreder
Journal:  Wien Med Wochenschr       Date:  1968-09-14

10.  [Clinical experimental studies with a new coronary and heart active beta-aminoketone].

Authors:  G Schleusing; H Mühlberg; H Trenckmann
Journal:  Z Gesamte Inn Med       Date:  1968-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.